Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reoperation for malignant astrocytoma.

N A Vick1, I S Ciric, T W Eller

  • 1Division of Neurology, Evanston Hospital, IL 60201.

Neurology
|March 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of bacterial contamination between disposable and cloth caps in an operating theatre setting.

Infection prevention in practice·2025
Same author

Social Deprivation among Children with Inherited Metabolic Disorders.

Irish medical journal·2025
Same author

Opportunistic Measles Immunisation within the Paediatric Inclusion Health Service.

Irish medical journal·2025
Same author

A case report of Penicillium chorioretinitis in a Border Collie dog.

Australian veterinary journal·2024
Same author

Meteorological gaps in audits of pedestrian environments: a scoping review.

BMC public health·2024
Same author

Impact and process evaluation of a primary-school Food Education and Sustainability Training (FEAST) program in 10-12-year-old children in Australia: pragmatic cluster non-randomized controlled trial.

BMC public health·2024

Reoperation for malignant astrocytomas can maintain functional status and double survival. Consider re-resection for recurrent tumors in accessible regions to improve outcomes.

Area of Science:

  • Neurosurgery
  • Oncology
  • Neurology

Background:

  • Malignant astrocytomas often recur, necessitating further treatment.
  • The role of reoperation in improving outcomes for these patients remains a critical question.

Purpose of the Study:

  • To evaluate the impact of reoperation on functional status and survival in patients with malignant astrocytomas.
  • To identify factors influencing outcomes after repeat surgery for recurrent astrocytoma.

Main Methods:

  • Retrospective analysis of 15 patients undergoing reoperation for malignant astrocytomas.
  • Assessment of Karnovsky Performance Status (KPS) before and after surgery.
  • Comparison of survival data with historical controls.

Main Results:

Related Experiment Videos

  • No perioperative deaths, infections, or complications were observed.
  • Karnovsky Performance Status (KPS) remained unchanged post-surgery.
  • Patients with glioblastoma maintained KPS for a mean of 13 weeks (median 10 weeks).
  • Patients with anaplastic astrocytoma maintained KPS for a mean of 37.2 weeks (median 24 weeks).
  • Reoperated patients experienced approximately double the lifespan of historical controls.

Conclusions:

  • Reoperation for malignant astrocytomas is safe and does not compromise functional status.
  • Reoperation can significantly improve survival in patients with recurrent malignant astrocytoma.
  • Gross total re-resection should be the goal for recurrent malignant astrocytomas in accessible brain regions.